Bernard Douglas
Pediatrics · Omaha, NENPI 1417062399
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 349 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 14.5% — the pattern of someone who eats at a lot of different presentations. Among pediatrics clinicians in NE with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 349 payments — averaging $17.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$895
- CSL Behring$888
- Grifols USA, LLC$734
- AstraZeneca$588
- Pharming Healthcare, Inc.$479
- Takeda Pharmaceuticals U.S.A., Inc.$469
- plus $2K from 27 others
What the payments were for
- Food & beverage$6,154100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 43 | $895 |
| CSL Behring | 54 | $888 |
| Grifols USA, LLC | 38 | $734 |
| AstraZeneca | 26 | $588 |
| Pharming Healthcare, Inc. | 29 | $479 |
| Takeda Pharmaceuticals U.S.A., Inc. | 35 | $469 |
| Genentech USA, Inc. | 14 | $319 |
| Biocryst US Sales Co., LLC | 17 | $305 |
| Amgen | 12 | $225 |
| Kaleo, Inc. | 12 | $164 |
| GSK | 8 | $105 |
| Novartis | 6 | $99 |
| Boehringer Ingelheim | 7 | $95 |
| Teva Pharmaceuticals USA, Inc. | 6 | $93 |
| Incyte Corporation | 5 | $83 |
| Alk-abello, Inc | 5 | $75 |
| Blueprint Medicines Corporation | 3 | $71 |
| Octapharma USA, Inc. | 3 | $64 |
| ARS Pharmaceuticals Operations, Inc. | 4 | $58 |
| Shire North American Group Inc | 4 | $47 |
| Seqirus USA Inc | 3 | $46 |
| Jazz Pharmaceuticals Inc. | 2 | $38 |
| Lilly USA, LLC | 2 | $36 |
| Optinose US, Inc. | 2 | $28 |
| Aimmune Therapeutics, Inc. | 1 | $24 |
| Sanofi-aventis U.S. LLC | 1 | $20 |
| Sanofi | 1 | $17 |
| Hologic Sales And Service, LLC | 1 | $16 |
| Organon | 1 | $15 |
| Ultragenyx Pharmaceutical Inc. | 1 | $15 |
| Pfizer | 1 | $15 |
| Ionis Pharmaceuticals, Inc. | 1 | $15 |
| Ironshore Pharmaceuticals Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,154 in reported general payments places this provider in the 95th percentile of 308 pediatrics providers in Nebraska.
Other pediatrics in Omaha
- Sachit PatelOmaha$91K
- Rachel AndersonOmaha$76K
- Amy LacroixOmaha$40K
- Hana NieburOmaha$25K
- Melissa Muff-LuettOmaha$16K
- Karl RothOmaha$12K
- Danita VelascoOmaha$11K
- Rachel TaylorOmaha$10K
- Philip BoucherOmaha$10K
- Joseph NovotnyOmaha$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.